Dr. Sparling is an Associate Professor, the CHF Paul and Ann Milburn Chair in Pediatric Diabetes and Endocrinology, and currently serves as the Associate Chief of the Section of Pediatric Diabetes and Endocrinology.
Dr. Sparling graduated summa cum laude from the University of Oklahoma in 2001 and went on to pursue his MD/PhD at the University of Oklahoma Health Sciences Center, completing his degrees in 2009. He completed his pediatrics residency and a fellowship in pediatric endocrinology at the New York-Presbyterian Morgan Stanley Children’s Hospital through the Columbia University College of Physicians and Surgeons.
He has a special clinical interest in type 1 diabetes mellitus, and his research focuses both on diagnosis and management of children with type 1 diabetes as the site primary investigator for TrialNet and previously with the Type 1 Diabetes Exchange. He also has been examining the role of adipocytes in inflammation. His initial NIH-funded research focused on the function of gamma secretase in adipocytes, and his current focus is on a novel adipokine that seems to be regulated in states of adipose cell turnover.